Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.

At the end of the day, one electrophysiologist explained, these decisions should still be made on a case-by-case basis.

AI can help care teams get additional value out of routine head CT images.

The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.

The risk appears to be greatest when patients are still actively taking antidepressants. Researchers noted that many more studies on this topic are still necessary.

The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects. 

PFA is still quite safe overall. However, new data out of EHRA 2026 suggest cardiologists have much to learn about minimizing risk during treatment. 

Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

The new approach allows private practices to expand and evolve without being acquired.

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

Almost 15% of more than 5,500 U.S. adults—representing around 14 million individuals—have skipped a doctor visit after feeling satisfied enough with health advice they received from AI.

Issues in dispute between the University of California and AFSCME Local 3299 include wage increases, insurance costs and access to housing programs. Union officials claim members are experiencing high rates of homelessness, fueled by rising cost of living in California.